Donate Now
HomeDr. Gauri Kapoor

Dr. Gauri Kapoor

MBBS, MD, PhD, MCRPCH

Medical Director RGCIRC, Nitibagh Director Pediatric Hematology & Oncology

Rajiv Gandhi Cancer Institute, Sector - 5, Rohini, Delhi - 110 085
Rajiv Gandhi Cancer Institute, Mahender Kumar Jain Marg, Niti Bagh, New Delhi, Delhi 110049

Book An Appointment

About

Dr. Gauri Kapoor is an alumnus of Lady Hardinge Medical College, New Delhi. She earned her PhD in Molecular Oncology from University of Delhi (ACBR).

Dr. Gauri Kapoor is a leading Pediatric Oncologist of National stature, she carries an experience of 26 years in Pediatric (Medical) Oncology. She has also worked with Tata Memorial Hospital, Mumbai and St. Jude Children's Research Hospital, Memphis, USA. She is a recipient of Heinz fellowship by Royal College of Pediatrics and Child Health, London.

Currently, she is Director and Head of Department of Pediatric Hematology - Oncology, Rajiv Gandhi Cancer Institute & Research Centre. She joined RGCI&RC in May 1997 and developed the Department of Pediatrics to its current premier status. National Board of Examination recognizes the Department for fellowship training of 2 post graduates in the subspecialty every year since 2008.

Dr Kapoor has donned many hats and chaired many committees with her dynamic leadership. She is currently the chairperson of the Pediatric Hematology Oncology chapter of Indian Academy of Pediatrics, Chair InPOG Late effects committee of IAPs and chairperson of Infection Control Committee, RGCI&RC. In recognition of her administrative skills she holds the additional responsibility of Medical Director of our Institute's Nitibagh facility in South Delhi. Her interest in academics and research is well known and she has more than 75 publications in peer reviewed journals.

Her areas of interest include pediatric leukemias, molecular oncology, stem cell transplant, survivorship and awareness programs for childhood cancer for general public as well as practitioners.

PROFESSIONAL JOURNEY

Achievements

  • Cytotoxic unit -From May 2012 to present have streamlined the unit in terms of quality of mixing, staff training, supervision and asepsis
  • Chair Pharmaco Therapeutic committee, RGCI&RC 2016-2017
  • Chairperson of the Pediatric Hematology Oncology chapter of IAP 2017-2018
  • Chair InPOG Late effects committee of IAP 2015-2017
  • Chairperson of Infection Control Committee, RGCI&RC (current)
  • Chemotherapy protocols standardized for nurses to reduce errors
  • Development of ACT clinic (after completion of therapy clinic )
  • Organised RGCON 2011 with theme of Pediatric Malignancies
  • ICMR guidelines committee for management protocols for childhood cancers

Awards

  • Fellowship in survivorship program (2016) at St Jude Children's Research Hospital, Memphis, TN, USA
  • Best Research Paper RGCON 2014, International Conference
  • Heinz fellowship by Royal College of Pediatrics and Child Health, London.
  • Awarded Gulati Foundation Fellowship (USA), for training in stem cells lab at New York Hospital, Cornell Medical Center, New York, 1996 (4 weeks)

Publication

  • Jain S, Jain S, Kapoor G*, Virmani A, Bajpai R.No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26271. Epub 2016 Sep 26.
  • Jain S, Kapoor G*, Bajpai R. ABVD-Based Therapy for Hodgkin Lymphoma in Children and Adolescents: Lessons Learnt in a Tertiary Care Oncology Center in a Developing Country. Pediatr Blood Cancer. 2016 Jun;63(6):1024-30. doi: 10.1002/pbc.25935. Epub 2016 Feb 8.
  • Radhakrishnan V, Kapoor G*, Arora B, Bansal D, Vora T, Prasad M, Chinnaswamy G, Laskar S, Agarwala S, Kaur T, Rath GK, Bakhshi S. Management of Hodgkins Lymphoma: ICMR Consensus Document. Indian J Pediatr. 2017 May;84(5):371-381. doi: 10.1007/s12098-017-2304-6. Epub 2017 Mar 30.
  • Bhethanabhotla S, Jain S, Kapoor G, Mahajan A, Chopra A, Vishnubhatla S, Bakhshi S. Outcome of pediatric advanced Hodgkin lymphoma treated with ABVD and predictors of inferior survival: a multicenter study of 186 patients. Leuk Lymphoma. 2017 Jul;58(7):1617-1623. doi: 10.1080/10428194.2016.1262951. Epub 2016 Dec 6.
  • Panda SP, Chinnaswamy G, Vora T, Prasad M, Bansal D, Kapoor G, Radhakrishnan V, Agarwala S, Laskar S, Arora B, Kaur T, Rath GK, Bakhshi S. Diagnosis and Management of Rhabdomyosarcoma in Children and Adolescents: ICMR Consensus Document. Indian J Pediatr. 2017 May;84(5):393-402. doi: 10.1007/s12098-017-2315-3. Epub 2017 Apr 5.
  • Thacker N, Bakhshi S, Chinnaswamy G, Vora T, Prasad M, Bansal D, Agarwala S, Kapoor G, Radhakrishnan V, Laskar S, Kaur T, Rath GK, Dhaliwal RS, Arora B. Management of Non-Hodgkin Lymphoma: ICMR Consensus Document. Indian J Pediatr. 2017 May;84(5):382-392. doi: 10.1007/s12098-017-2318-0. Epub 2017 Apr 5.
  • Bansal D, Totadri S, Chinnaswamy G, Agarwala S, Vora T, Arora B, Prasad M, Kapoor G, Radhakrishnan V, Laskar S, Kaur T, Rath GK, Bakhshi S. Management of Neuroblastoma: ICMR Consensus Document. Indian J Pediatr. 2017 Jun;84(6):446-455. doi: 10.1007/s12098-017-2298-0. Epub 2017 Apr 3.
  • Prasad M, Vora T, Agarwala S, Laskar S, Arora B, Bansal D, Kapoor G, Chinnaswamy G, Radhakrishnan V, Kaur T, Rath GK, Bakhshi S. Management of Wilms Tumor: ICMR Consensus Document. Indian J Pediatr. 2017 Jun;84(6):437-445. doi: 10.1007/s12098-017-2305-5. Epub 2017 Apr 3.
  • Agarwala S, Mitra A, Bansal D, Kapoor G, Vora T, Prasad M, Chinnaswamy G, Arora B, Radhakrishnan V, Laskar S, Kaur T, Dhaliwal RS, Rath GK, Bakhshi S. Management of Pediatric Malignant Germ Cell Tumors: ICMR Consensus Document. Indian J Pediatr. 2017 Jun;84(6):465-472. doi: 10.1007/s12098-017-2308-2. Epub 2017 Apr 1.
  • Agarwala S, Gupta A, Bansal D, Vora T, Prasad M, Arora B, Kapoor G, Chinnaswamy G, Radhakrishnan V, Laskar S, Kaur T, Dhaliwal RS, Rath GK, Bakhshi S. Management of Hepatoblastoma: ICMR Consensus Document. Indian J Pediatr. 2017 Jun;84(6):456-464. doi: 10.1007/s12098-017-2301-9. Epub 2017 Mar 29.
  • Kapoor G, Maitra A, Somlata, Brahmachari V. Application of SNaPshot for analysis of thiopurine methyltransferase gene polymorphism. Indian J Med Res May;2009.500-505.
  • Abedin S, Kapoor G. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer. Pediatr Blood Cancer. 2008 Aug;51(2):251-5.
  • Kapoor G, Rupal Sinha, Rahul Naithani, Meenal Chandgothia. Thiopurine Smethyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia. Leukemia Research 2010;34(8),1023-36
  • Kunal, Gupta H, Kapoor G. Non-Hematological tumors of head and neck region in the pediatric age group in a tertiary care cancer centre. Pediatric Surgery International Sep2011, Vol. 27 Issue 9, p919 DOI: 10.1007/s00383-011-2916-2.
  • Kapoor G, Sinha R, Abedin S. Experience with high dose methotrexate therapy in childhood acute lymphoblastic leukemia in a tertiary care cancer centre of a developing country. Pediatr Blood Cancer. 2012 Sep;59(3):448-53. doi: 10.1002/pbc.24081. Epub 2012 Jan 23.
  • Dhamija M, Kapoor G, Juneja A. Infusional Chemotherapy and Medication Errors in a Tertiary Care Pediatric Cancer Unit in a Resource-limited Setting. J Pediatr Hematol Oncol. 2013 Oct 16. [Epub ahead of print]
  • Jain S, Kapoor G. Invasive aspergillosis in children with acute leukemia at a resource limited oncology center. J Pediatr Hematol Oncol. 2014 Mar 28. [Epub ahead of print] COMPLETE LIST OF PUBLICATIONS International Journals
  • Dhamija M, Kapoor G, Juneja A .Infusional Chemotherapy and Medication Errors in a Tertiary Care Pediatric Cancer Unit in a Resource-limited Setting. J Pediatr Hematol Oncol.2013 Oct 16. [Epub ahead of print] PMID: 24136029
  • Kapoor G, Rupal Sinha, Sarfraz Abedin. Experience with High Dose Methotrexate Therapy in Childhood Acute Lymphoblastic Leukemia in a Tertiary Care Cancer Centre of a Developing Country. Pediatr Blood Cancer 2012;59:448-453.
  • Das K, Jain S, Chichra A, Gupta H, Kapoor G. Non-hematological tumors of head and neck region in the pediatric age group in a tertiary care cancer center. Pediatr Surg Int.2011 Sep;27(9):919-23.
  • Kapoor G, Sinha R, Naithani R, Chandgothia M. Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia. Leukemia Res 2010;34(8),1023-36.
  • Yadav SP, Kharya G, Mohan N, Sehgal A, Bhat S, Jain S, Kapoor G, Sachdeva A. Langerhans cell histiocytosis with digestive tract involvement. Pediatr Blood Cancer.2010 Oct;55(4):748-53.
  • Jain S, Kapoor G.Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine. Pediatr Blood Cancer. 2010 May;54(5):783.
  • Saha R, Jain S, Naithani R, Kapoor G. Chemotherapy-induced palmoplantar erythrodysesthesia in a child with Burkitt lymphoma. Pediatr Blood Cancer. 2009 Oct;53(4):682.
  • Jain S, Naithani R, Kapoor G, Nath T. L-asparaginase induced severe hypertriglyceridemia in acute lymphoblastic leukemia with 11q23abnormality. Leuk Res.2009 Nov;33(11):e194.
  • Abedin S, Kapoor G. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer. Pediatr Blood Cancer. 2008 Aug;51(2):251-5.
  • Pavithran K, Kapoor G. Letter to the editor: acute myeloid leukemia in a child with Kapoor G, Kumar Prabhash. Childhood acute lymphoblastic leukemia : experience with a moderately aggressive protocol in a developing country. Pediatric Blood and Cancer.2004;
  • Shearer P, Kapoor G etal. Secondary AML in Wilms tumor. American Journal of Pediatric Hematology-Oncology,2001 Feb;23(2):109-111.
  • Kapoor G, Albrecht R, Craver R, et al. Diffuse large cell lymphoma presenting as inflammatory bowel disease in an adolescent with ataxia telangiectasia. Leukemia Research 20:997-998,1996.
  • Kapoor G, Bajpai S, Nair CN, et al. Calla positive acute lymphoblastic leukemia following etoposide based chemotherapy for Ewing's sarcoma. Leukemia Research,19(10):771-772, 1995.
  • Kapoor G, Advani SH, Nair CN, et al. Pediatric germ cell tumor: An experience with BEP. Am J Pediatr Hematol Oncol 17(4):318-324, 1995.
  • Kapoor G, Advani SH, Dinshaw KA, et al. Treatment results of Hodgkin's disease in Indian Children. Pediatr Hematol Oncol 12(6):559-569, 1995.
  • Kapoor G, Yu LC. Essential thrombocythemia. American Journal of Pediatric Hematology-Oncology 18:381-383,1996

Specialized Areas

  • Pediatric leukemias
  • Molecular oncology
  • Stem cell transplant
  • Childhood cancer survivorship
  • Awareness programs for childhood cancer

Educational Background

  • MRCPCH June 2001, London.
  • PhD Ph.D. under supervision of Prof. Vani Brahmachari (Dr. B.R. Ambedkar Center for Biomedical Research, Delhi University) Molecular Biology of Acute Lymphoblastic Leukemia
  • MD (Pediatrics) Lady Hardinge Medical College, Delhi University, New Delhi, India
  • MBBS Lady Hardinge Medical College, Delhi University, New Delhi, India

Membership

  • International Society of Pediatric Oncology (SIOP)
  • Children's Oncology Group (COG)
  • Americal Society of Hematology (ASH)
  • Americal Society of Clinical Oncology (ASCO)
  • Indian Academy of Pediatrics
  • Pediatric Hematology Oncology chapter of Indian Academy of Pediatrics (PHO)

Book An Appointment

Follow us
Accredited by:
All © reserved to Rajiv Gandhi Cancer Institute & Research Centre
Website Designing & SEO by Techmagnate